5-MeO-2-TMT

5-MeO-2-TMT
Clinical data
Other names5-Methoxy-2,N,N-trimethyltryptamine; 5-MeO-2,N,N-TMT; 5-MeO-TMT; 2-Methyl-5-methoxy-N,N-dimethyltryptamine; 2-Me-5-MeO-DMT; Indapex; MMDT; 5-Methoxy-2-methyl-DMT
Routes of
administration		Oral
Drug classSerotonin receptor modulator; Serotonergic psychedelic; Hallucinogen
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class A
Pharmacokinetic data
Duration of action5–10 hours
Identifiers
  • 2-(5-methoxy-2-methyl-1H-indol-3-yl)-N,N-dimethylethanamine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H20N2O
Molar mass232.327 g·mol−1
3D model (JSmol)
  • CC1=C(C2=C(N1)C=CC(=C2)OC)CCN(C)C
  • InChI=1S/C14H20N2O/c1-10-12(7-8-16(2)3)13-9-11(17-4)5-6-14(13)15-10/h5-6,9,15H,7-8H2,1-4H3 Y
  • Key:ACEHBQPPDDGCGZ-UHFFFAOYSA-N Y
  (verify)

5-Methoxy-2,N,N-trimethyltryptamine (5-MeO-2,N,N-TMT, 5-MeO-TMT), also known as 2-methyl-5-methoxy-N,N-dimethyltryptamine (2-Me-5-MeO-DMT), is a serotonin receptor modulator and psychedelic drug of the tryptamine and 2-alkyltryptamine families. It was first synthesized by Alexander Shulgin and reported in his 1997 book TiHKAL (Tryptamines I Have Known and Loved).

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.